JAGX - Jaguar Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
6,023
4,416
4,361
142
258
Cost of Revenue
3,819
2,766
880
52
123
Gross Profit
2,205
1,650
3,481
90
135
Operating Expenses
Research Development
5,911
5,155
4,269
7,207
6,476
Selling General and Administrative
22,097
22,109
14,331
6,469
6,104
Total Operating Expenses
28,008
27,264
18,601
13,676
12,580
Operating Income or Loss
-25,803
-25,613
-15,120
-13,586
-12,445
Interest Expense
5,519
2,629
1,210
986
3,317
Total Other Income/Expenses Net
-12,495
-3,904
-18,820
-162
-529
Income Before Tax
-43,817
-32,146
-35,150
-14,734
-16,292
Income Tax Expense
-
0
-13,181
-
-
Income from Continuing Operations
-43,817
-32,146
-21,969
-14,734
-16,292
Net Income
-43,817
-32,146
-21,969
-14,734
-16,292
Net Income available to common shareholders
-42,822
-32,146
-21,969
-14,734
-16,638
Reported EPS
Basic
-
-153.30
-535.49
-1.42k
-2.83k
Diluted
-
-153.30
-535.49
-1.42k
-2.83k
Weighted average shares outstanding
Basic
-
210
41
10
6
Diluted
-
210
41
10
6
EBITDA
-
-28,198
-33,356
-13,701
-12,969